PT  - JOURNAL ARTICLE
AU  - Liu, Ruoqi
AU  - Chen, Pin-Yu
AU  - Zhang, Ping
TI  - CURE: A Pre-training Framework on Large-scale Patient Data for Treatment Effect Estimation
AID  - 10.1101/2022.09.09.22279776
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.09.09.22279776
4099  - http://medrxiv.org/content/early/2022/09/10/2022.09.09.22279776.short
4100  - http://medrxiv.org/content/early/2022/09/10/2022.09.09.22279776.full
AB  - Treatment effect estimation (TEE) refers to the estimation of causal effects, and it aims to compare the difference among treatment strategies on important outcomes. Current machine learning based methods are mainly trained on labeled data with specific treatments or outcomes of interest, which can be sub-optimal if the labeled data are limited. In this paper, we propose a novel transformer-based pre-training and fine-tuning framework called CURE for TEE from observational data. CURE is pre-trained on large-scale unlabeled patient data to learn representative contextual patient representations, and then fine-tuned on labeled patient data for TEE. We design a new sequence encoding for longitudinal (or structured) patient data and we incorporate structure and time into patient embeddings. Evaluated on 4 downstream TEE tasks, CURE outperforms the state-of-the-art methods in terms of an average of 3.8% and 6.9% absolute improvement in Area under the ROC Curve (AUC) and Area under the Precision-Recall Curve (AUPR), and 15.7% absolute improvement in Influence function-based Precision of Estimating Heterogeneous Effects (IF-PEHE). We further demonstrate the data scalability of CURE and verify the results with corresponding randomized clinical trials. Our proposed method provides a new machine learning paradigm for TEE based on observational data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe experimental data can be obtained from IBM MarketScan Research Databases. https://www.ibm.com/products/marketscan-research-databases